A melanin mark for hypercalcemia
Earlier detection of disease could help improve response to therapy. Blood calcium concentrations are elevated in several types of cancer, in addition to other diseases. Here, Tastanova et al. used synthetic biology and cell engineering to develop a sensor that detects hypercalcemia. Their implantable sensor consists of cells that express the calcium-sensing receptor and produce melanin in response to sustained elevated calcium in the blood. Melanin was visible as a dark pigment in the encapsulated cell constructs in vitro and could be detected when implanted in pig skin ex vivo. Melanin production was also observed in engineered cells implanted in mice bearing hypercalcemic breast and colon cancer tumors. This biomedical tattoo strategy could also potentially be used to noninvasively monitor response to treatment.
- Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
This is an article distributed under the terms of the Science Journals Default License.